glp-1 therapies Drugs & What They Do GLP-1 Therapies and Dermatology: A

Call your PCC

The short-acting (25 h half-life) and the long-acting (several to 12 h half-life) GLP-1 receptor agonists have considerable effects on the treatment of not only diabetes but also obesity

So the review reframes where the opportunity is

Some practical dietary strategies include: Smaller portion sizes : Eating until comfortably satisfied rather than full reduces the risk of nausea and discomfort Bland, easily digestible foods : During dose escalation, focus on lean proteins, whole grains, and cooked vegetables Adequate hydration : Sipping water throughout the day, particularly if experiencing nausea or constipation Avoiding trigger foods : Identifying and temporarily limiting foods that worsen individual symptoms Persistent vomiting or diarrhea can lead to dehydration and potentially acute kidney injury

Kokura Y et al

Company Structure Disclosure: OzemPatches is sold through a multi-entity structure involving Haur B.V